Middle East Healthcare Company

SASE:4009 株式レポート

時価総額：ر.س6.5b

Middle East Healthcare 将来の成長

Future 基準チェック /26

Middle East Healthcare利益と収益がそれぞれ年間14%と8.3%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に17.8% 13%なると予測されています。

主要情報

14.0%

収益成長率

13.0%

EPS成長率

Healthcare 収益成長14.7%
収益成長率8.3%
将来の株主資本利益率17.8%
アナリストカバレッジ

Good

最終更新日24 Mar 2025

今後の成長に関する最新情報

Middle East Healthcare Company (TADAWUL:4009) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Aug 09
Middle East Healthcare Company (TADAWUL:4009) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Middle East Healthcare Company Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

May 09
Middle East Healthcare Company Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Recent updates

Insufficient Growth At Middle East Healthcare Company (TADAWUL:4009) Hampers Share Price

Apr 29
Insufficient Growth At Middle East Healthcare Company (TADAWUL:4009) Hampers Share Price

With EPS Growth And More, Middle East Healthcare (TADAWUL:4009) Makes An Interesting Case

Apr 07
With EPS Growth And More, Middle East Healthcare (TADAWUL:4009) Makes An Interesting Case

Shareholders Will Be Pleased With The Quality of Middle East Healthcare's (TADAWUL:4009) Earnings

Mar 10
Shareholders Will Be Pleased With The Quality of Middle East Healthcare's (TADAWUL:4009) Earnings

Middle East Healthcare (TADAWUL:4009) Might Have The Makings Of A Multi-Bagger

Feb 21
Middle East Healthcare (TADAWUL:4009) Might Have The Makings Of A Multi-Bagger

With EPS Growth And More, Middle East Healthcare (TADAWUL:4009) Makes An Interesting Case

Dec 16
With EPS Growth And More, Middle East Healthcare (TADAWUL:4009) Makes An Interesting Case

Investors Will Want Middle East Healthcare's (TADAWUL:4009) Growth In ROCE To Persist

Sep 24
Investors Will Want Middle East Healthcare's (TADAWUL:4009) Growth In ROCE To Persist

Middle East Healthcare Company (TADAWUL:4009) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Aug 09
Middle East Healthcare Company (TADAWUL:4009) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Middle East Healthcare Company's (TADAWUL:4009) Price In Tune With Earnings

Jul 18
Middle East Healthcare Company's (TADAWUL:4009) Price In Tune With Earnings

There's Been No Shortage Of Growth Recently For Middle East Healthcare's (TADAWUL:4009) Returns On Capital

May 30
There's Been No Shortage Of Growth Recently For Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Middle East Healthcare Company Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

May 09
Middle East Healthcare Company Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

If EPS Growth Is Important To You, Middle East Healthcare (TADAWUL:4009) Presents An Opportunity

Apr 29
If EPS Growth Is Important To You, Middle East Healthcare (TADAWUL:4009) Presents An Opportunity

Why Investors Shouldn't Be Surprised By Middle East Healthcare Company's (TADAWUL:4009) 27% Share Price Plunge

Apr 02
Why Investors Shouldn't Be Surprised By Middle East Healthcare Company's (TADAWUL:4009) 27% Share Price Plunge

There's Reason For Concern Over Middle East Healthcare Company's (TADAWUL:4009) Massive 40% Price Jump

Feb 11
There's Reason For Concern Over Middle East Healthcare Company's (TADAWUL:4009) Massive 40% Price Jump

Returns On Capital At Middle East Healthcare (TADAWUL:4009) Have Stalled

Feb 08
Returns On Capital At Middle East Healthcare (TADAWUL:4009) Have Stalled

Should You Be Adding Middle East Healthcare (TADAWUL:4009) To Your Watchlist Today?

Jan 18
Should You Be Adding Middle East Healthcare (TADAWUL:4009) To Your Watchlist Today?

Middle East Healthcare Company's (TADAWUL:4009) Revenues Are Not Doing Enough For Some Investors

Dec 28
Middle East Healthcare Company's (TADAWUL:4009) Revenues Are Not Doing Enough For Some Investors

Middle East Healthcare (TADAWUL:4009) Will Want To Turn Around Its Return Trends

Sep 26
Middle East Healthcare (TADAWUL:4009) Will Want To Turn Around Its Return Trends

Some Investors May Be Worried About Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Jun 28
Some Investors May Be Worried About Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Investors Could Be Concerned With Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Mar 30
Investors Could Be Concerned With Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Capital Allocation Trends At Middle East Healthcare (TADAWUL:4009) Aren't Ideal

Sep 20
Capital Allocation Trends At Middle East Healthcare (TADAWUL:4009) Aren't Ideal

Calculating The Intrinsic Value Of Middle East Healthcare Company (TADAWUL:4009)

Jun 14
Calculating The Intrinsic Value Of Middle East Healthcare Company (TADAWUL:4009)

Returns On Capital At Middle East Healthcare (TADAWUL:4009) Paint A Concerning Picture

Apr 18
Returns On Capital At Middle East Healthcare (TADAWUL:4009) Paint A Concerning Picture

Here's What's Concerning About Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Aug 10
Here's What's Concerning About Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Middle East Healthcare (TADAWUL:4009) Will Will Want To Turn Around Its Return Trends

Mar 29
Middle East Healthcare (TADAWUL:4009) Will Will Want To Turn Around Its Return Trends

An Intrinsic Calculation For Middle East Healthcare Company (TADAWUL:4009) Suggests It's 28% Undervalued

Mar 03
An Intrinsic Calculation For Middle East Healthcare Company (TADAWUL:4009) Suggests It's 28% Undervalued

Are Middle East Healthcare's (TADAWUL:4009) Statutory Earnings A Good Guide To Its Underlying Profitability?

Feb 10
Are Middle East Healthcare's (TADAWUL:4009) Statutory Earnings A Good Guide To Its Underlying Profitability?

Weak Financial Prospects Seem To Be Dragging Down Middle East Healthcare Company (TADAWUL:4009) Stock

Jan 23
Weak Financial Prospects Seem To Be Dragging Down Middle East Healthcare Company (TADAWUL:4009) Stock

If You Had Bought Middle East Healthcare's (TADAWUL:4009) Shares Three Years Ago You Would Be Down 38%

Jan 05
If You Had Bought Middle East Healthcare's (TADAWUL:4009) Shares Three Years Ago You Would Be Down 38%

Should You Be Impressed By Middle East Healthcare's (TADAWUL:4009) Returns on Capital?

Dec 18
Should You Be Impressed By Middle East Healthcare's (TADAWUL:4009) Returns on Capital?

Calculating The Fair Value Of Middle East Healthcare Company (TADAWUL:4009)

Nov 30
Calculating The Fair Value Of Middle East Healthcare Company (TADAWUL:4009)

業績と収益の成長予測

SASE:4009 - アナリストの将来予測と過去の財務データ ( )SAR Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/20273,8334124935895
12/31/20263,5703443744816
12/31/20253,2052842305026
12/31/20242,883282287766N/A
9/30/20242,854211203665N/A
6/30/20242,793203-23196N/A
3/31/20242,70418269270N/A
12/31/20232,65317-41191N/A
9/30/20232,55117723282N/A
6/30/20232,39313563346N/A
3/31/20232,276105-95172N/A
12/31/20222,15275-17476N/A
9/30/20222,03324-2929N/A
6/30/20222,01927-3091N/A
3/31/20221,96826-259114N/A
12/31/20211,87317-34177N/A
9/30/20211,82345-434-37N/A
6/30/20211,81666-580-160N/A
3/31/20211,73373-501-166N/A
12/31/20201,75182-524-229N/A
9/30/20201,708110-507-182N/A
6/30/20201,603108-348-23N/A
3/31/20201,583104-440-38N/A
12/31/20191,49798-37399N/A
9/30/20191,40191-351133N/A
6/30/20191,35378-335180N/A
3/31/20191,346100-289164N/A
12/31/20181,391172-197159N/A
9/30/20181,445224N/A317N/A
6/30/20181,459269N/A204N/A
3/31/20181,464297N/A135N/A
12/31/20171,462319N/A347N/A
9/30/20171,503322N/A370N/A
6/30/20171,529356N/A256N/A
3/31/20171,588368N/A453N/A
12/31/20161,616363N/A253N/A
9/30/20161,629380N/A72N/A
6/30/20161,602371N/A313N/A
3/31/20161,564389N/A303N/A
12/31/20151,535390N/A194N/A
9/30/20151,485373N/A434N/A
6/30/20151,456356N/A383N/A
3/31/20151,431357N/A253N/A
12/31/20141,399332N/A349N/A

アナリストによる今後の成長予測

収入対貯蓄率: 4009の予測収益成長率 (年間14% ) は 貯蓄率 ( 14.9% ) を下回っています。

収益対市場: 4009の収益 ( 14% ) はSA市場 ( 7.1% ) よりも速いペースで成長すると予測されています。

高成長収益: 4009の収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: 4009の収益 ( 8.3% ) SA市場 ( 2.5% ) よりも速いペースで成長すると予測されています。

高い収益成長: 4009の収益 ( 8.3% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: 4009の 自己資本利益率 は、3年後には低くなると予測されています ( 17.8 %)。

成長企業の発掘

7D

1Y

7D

1Y

7D

1Y

企業分析と財務データの現状

データ最終更新日（UTC時間）
企業分析2025/05/07 04:05
終値2025/05/07 00:00
収益2024/12/31
年間収益2024/12/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

このレポートの作成に使用した分析モデルの詳細は、Githubページでご覧いただけます。また、レポートの使用方法に関するガイドや、Youtubeでのチュートリアルもご用意しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

Middle East Healthcare Company 6 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。10

アナリスト機関
Jassim Al-JubranAljazira Capital Company
Madhu AppissaAl Rajhi Capital
Christine KalindjianArqaam Capital Research Offshore S.A.L.